Ask AI

Missed Opportunities in Heart Failure Care: Supporting Early Diagnosis With Cardiac Biomarkers and Maximizing Treatment Potential With SGLT2 Inhibitors

Deepen your understanding of the clinical symptoms of heart failure, current evidence regarding SGLT2 inhibitors as a key treatment strategy, and how to personalize care plans across the heart failure spectrum, through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast. 

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company